n,n-dimethylarginine has been researched along with fenofibrate in 3 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (fenofibrate) | Trials (fenofibrate) | Recent Studies (post-2010) (fenofibrate) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 3,058 | 529 | 1,354 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | fenofibrate (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.371 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.701 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.118 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.371 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 8.633 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 1 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode-Böger, SM; Dierkes, J; Luley, C; Martens-Lobenhoffer, J; Westphal, S | 1 |
| Chen, MF; Li, YJ; Luo, BL; Xia, X; Yang, TL | 1 |
| Huang, F; Jiang, J; Sun, B; Wang, Y; Xie, Y; Xu, X; Zhao, C | 1 |
2 trial(s) available for n,n-dimethylarginine and fenofibrate
| Article | Year |
|---|---|
Fenofibrate increases the L-arginine:ADMA ratio by increase of L-arginine concentration but has no effect on ADMA concentration.
Topics: Adult; Arginine; Biomarkers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fenofibrate; Follow-Up Studies; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia.
Topics: Adult; Anticholesteremic Agents; Arginine; Blood Flow Velocity; Brachial Artery; Cholesterol; Cholesterol, HDL; Diet; Endothelium, Vascular; Female; Fenofibrate; Humans; Hypertriglyceridemia; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Vasodilation | 2006 |
1 other study(ies) available for n,n-dimethylarginine and fenofibrate
| Article | Year |
|---|---|
Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.
Topics: Animals; Apolipoprotein A-I; Arginine; C-Reactive Protein; Cardiotonic Agents; Cholesterol, HDL; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triglycerides | 2015 |